NCT00741897View on ClinicalTrials.gov

Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL

Enrollment

264

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

December 31, 2003

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG

Fexofenadine

Fexofenadine: One 30 mg Tablet once daily for two weeks

Trial Locations (1)

Unknown

Sanofi-aventis administrative office, Makati City

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY